As seen in the CDC’s recent reports, 0.6 per 100,000 people were hospitalized in mid-April with confirmed hospital admissions averaging between 800 to 900 in June 2026. In addition, the WHO reports 1,057 newly hospitalized individuals and 105 ICU admissions among thirty participating countries during the period April 20 to May 17, 2026.
A Cumulative Report for April/May2026
Looking back to April 2026, the CDC’s cumulative report for that period in the U.S. registers over 139 pediatric deaths and approximately 250,000 people hospitalized worldwide. Despite prior efforts, the season included a new mutation of Influenza A called H3N2 also known as subclade K. The new mutation was responsible for 90% of cases associated with the vaccine, allowing it to spread quickly and avoid immunity.
Nevertheless, the vaccine proved to be effective.
Adult hospitalizations were reduced by approximately thirty percent while children’s numbers were reduced by forty percent. However, vaccine protection was low. Only fifty percent of eligible children and adults received their shots by April 2026.
Note that instead of occurring during the typical peak January/February season, the surge occurred in January 2026.
Protective Vaccinations
Fewer than fifty percent of children and adults opted for protection by the latter part of February. In March 2026 the FDA, in an effort to provide improved protection, recommended that three elements of the vaccines should be updated.
A Self Administered Nasal Spray
A timely addition to the arsenal in the 2025-26 season was the first self-administered nasal spray vaccine called FluMist that was approved in late 2024. FluMist works to prevent influenza in individuals from age 2 through age 49. The vaccine is comparable to the flu shot as it triggers the immune system to build antibodies.
FluMist is not recommended for people who are over fifty due to weakened immune responses.
Editor’s Note: The aforementioned is for informational purposes only. For medical advice or diagnosis, please consult a professional.
What are your thoughts about becoming a rare disease advocate? Share your stories, thoughts, and hopes with the Patient Worthy Community!
Rose Duesterwald June 21, 2026
